XML 26 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Marketable Securities
3 Months Ended
Apr. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities Marketable Securities
The following is a summary of our marketable securities (in thousands): 
As of April 30, 2023
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated Fair Value
Commercial paper$63,814 $— $— $63,814 
Treasury bills and U.S. government securities370,011 — (379)369,632 
Corporate bonds24,968 — (35)24,933 
Municipal bonds3,767 — (36)3,731 
Agency bonds12,697 — (26)12,671 
Total marketable securities$475,257 $— $(476)$474,781 
As of January 31, 2023
Amortized CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Estimated Fair Value
Commercial paper$62,470 $— $— $62,470 
Treasury bills and U.S. government securities (1)
234,848 — (308)234,540 
Corporate bonds46,684 — (198)46,486 
Municipal bonds6,374 — (66)6,308 
Agency bonds7,959 — (47)7,912 
Total marketable securities$358,335 $— $(619)$357,716 
(1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less.
As of April 30, 2023 and January 31, 2023, respectively $5.7 million and $2.9 million of our marketable securities had remaining contractual maturities of one year or more, and the remainder had contractual maturities of less than one year.
As of April 30, 2023 and January 31, 2023, $2.8 million and $3.5 million of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of April 30, 2023 and January 31, 2023.
Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the
extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.